SURGICEL Absorbable Hemostat
FDA premarket approval N12159/S077 · decided 2020-12-22
Approval details
- PMA number
- N12159
- Supplement
- S077
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- SURGICEL Absorbable Hemostat
- Generic name
- Agent, absorbable hemostatic, non-collagen based
- Applicant
- ETHICON, Inc.
- Date received
- 2020-11-25
- Decision date
- 2020-12-22
- Days to decision
- 27 days
- Decision code
- OK30
- Product code
- LMG
- Advisory committee
- General, Plastic Surgery
- Expedited review
- No
- Location
- Raritan, NJ
- Statement
- Implementation of X-Ray Sterilization as an alternative to Gamma Sterilization for SURGICEL Absorbable Hemostats at the Ethicon Sarl, Neuchatel Manufacturing site.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.